Nuveen Asset Management

Nuveen Asset Management Portfolio holdings

AUM $354B
1-Year Return 34.48%
 

Nuveen Asset Management, founded in 1898 by John Nuveen and headquartered in Chicago, Illinois, is a leading global investment manager and subsidiary of TIAA, overseeing hundreds of billions in assets with a focus on fixed income, equities, and sustainable investing. Initially known for municipal bonds, Nuveen has expanded into a broad range of strategies, including mutual funds, ETFs, closed-end funds, and private capital solutions, serving institutional investors, financial advisors, and individuals. The firm emphasizes income-generating investments and ESG (environmental, social, governance) integration, leveraging its deep research capabilities and a century-long legacy in the bond market. With a strong presence in North America and growing international reach, Nuveen blends tradition with innovation to meet diverse client needs in the evolving investment landscape.

This Quarter Return
-3.74%
1 Year Return
+34.48%
3 Year Return
+60.43%
5 Year Return
+189.89%
10 Year Return
+390.34%
AUM
$309B
AUM Growth
-$29.4B
Cap. Flow
-$6.05B
Cap. Flow %
-1.96%
Top 10 Hldgs %
22.53%
Holding
3,386
New
44
Increased
1,590
Reduced
1,481
Closed
89

Sector Composition

1 Technology 24.82%
2 Financials 12.45%
3 Healthcare 12.44%
4 Consumer Discretionary 11.85%
5 Industrials 8.4%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
DNTH icon
3126
Dianthus Therapeutics
DNTH
$853M
$238K ﹤0.01%
4,417
FOA icon
3127
Finance of America Companies
FOA
$308M
$237K ﹤0.01%
7,574
+152
+2% +$4.76K
ABOS icon
3128
Acumen Pharmaceuticals
ABOS
$87.2M
$235K ﹤0.01%
39,241
+26,319
+204% +$158K
EVI icon
3129
EVI Industries
EVI
$362M
$234K ﹤0.01%
12,138
CDAK
3130
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
$234K ﹤0.01%
37,184
WGS icon
3131
GeneDx Holdings
WGS
$3.81B
$233K ﹤0.01%
+2,514
New +$233K
QTNT
3132
DELISTED
Quotient Limited Ordinary Shares
QTNT
$232K ﹤0.01%
5,808
+125
+2% +$4.99K
HARP
3133
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$231K ﹤0.01%
5,104
AKYA
3134
DELISTED
Akoya BioSciences
AKYA
$230K ﹤0.01%
19,626
GBL
3135
DELISTED
GAMCO Investors, Inc.
GBL
$225K ﹤0.01%
10,736
TIG
3136
DELISTED
Trean Insurance Group, Inc. Common Stock
TIG
$224K ﹤0.01%
44,975
SWT
3137
DELISTED
Stanley Black & Decker, Inc.
SWT
0
-$269K
SOL
3138
Emeren Group
SOL
$96.5M
$223K ﹤0.01%
38,300
-2,900
-7% -$16.9K
RAIN
3139
DELISTED
Rain Oncology Inc. Common Stock
RAIN
$223K ﹤0.01%
32,437
BOLT icon
3140
Bolt Biotherapeutics
BOLT
$9.96M
$221K ﹤0.01%
3,764
-617
-14% -$36.2K
BMEA icon
3141
Biomea Fusion
BMEA
$114M
$219K ﹤0.01%
39,622
OMGA
3142
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
$219K ﹤0.01%
+31,685
New +$219K
TECX
3143
Tectonic Therapeutic, Inc. Common Stock
TECX
$314M
$218K ﹤0.01%
11,492
+315
+3% +$5.98K
GOTU icon
3144
Gaotu Techedu
GOTU
$877M
$217K ﹤0.01%
126,300
-80,017
-39% -$137K
QD
3145
Qudian
QD
$733M
$217K ﹤0.01%
184,200
-13,380
-7% -$15.8K
VTYX icon
3146
Ventyx Biosciences
VTYX
$180M
$215K ﹤0.01%
15,829
ERNA icon
3147
Eterna Therapeutics
ERNA
$9.59M
$214K ﹤0.01%
351
+9
+3% +$5.49K
HOFV
3148
DELISTED
Hall of Fame Resort & Entertainment Co
HOFV
$212K ﹤0.01%
8,301
+189
+2% +$4.83K
HOOK
3149
DELISTED
HOOKIPA Pharma
HOOK
$212K ﹤0.01%
13,097
-3,527
-21% -$57.1K
HLTH
3150
DELISTED
Cue Health Inc. Common Stock
HLTH
$212K ﹤0.01%
32,822
+10,689
+48% +$69K